Source: BioPortfolio

Ellipse Technology: NuVasive Buys Skeletal Specialist in First Deal under New CEO

San Diegos NuVasive NASDAQ NUVA a medical device maker that specializes in spinal procedures said today it is acquiring privately held Ellipse Technologies for $380 million in cash with an additional $30 million in potential milestone payments. Ellipse an ...

Read full article ยป
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Ed Roschak's photo - President & CEO of Ellipse Technology

President & CEO

Ed Roschak

CEO Approval Rating

68/100

Read more